Lightspeed-backed @CatoNetworks has launched the Cato MSASE Partner Platform, a new commercial and technical framework that gives vendor-level powers to partners.
Read more about Cato’s new platform here: https://t.co/D4k8q77uOZ
cc @YoniCheifetz@ravi_lsvp
Since @Lightspeedvp’s initial investment in @Pontera years ago, we've believed in their product & mission to help financial advisors looking to better serve their clients. Today we are excited to reaffirm our support with our latest investment. Congrats to @YoavZurel and the team
401(k) plans account for nearly one-fifth of the US retirement market. With our recent funding round, Pontera further advances our mission to help retirement savers receive professional management of this critical asset. Read more in @Reuters: https://t.co/NQV5Qm0r3c
Working with a Founder like Gilad Almogy means diving deep into his vision and trusting and supporting his long-term mission. It’s been incredible to partner with the team at @UltimaGenomics and be part of their story and growth.
Dive into their story: https://t.co/Nf8R4ca438
Finding new frontiers to inspire innovation is just one of the reasons why Shlomo stood out to us at @lightspeedvp. @CatoNetworks adapts to every cyber threat to keep your data safe.
His full story: https://t.co/ESeHp00LT4
#LightspeedFounderStories
We’re proud to announce our re-investment in Capitola, the first digital marketplace for commercial insurance.
“Our platform brings together brokers and underwriters, removing many of the operational inefficiencies…to allow them to focus on what they do best.” - Sivan Iram, Capitola Co-founder & CEO.
https://t.co/t3dbn7Kqjk
.@OligoSecurityOn is on a mission to help teams use open source in a secure and effective way.
We're excited to announce our investment in their work to address open-source vulnerabilities. Learn more via @TechCrunch.
Cc: @YoniCheifetz
https://t.co/tYXoYN3JyL
Congratulations to @UltimaGenomics and its UG100™ sequencer for being recognized as one of @TheScientistLLC's "Top 10 Innovations of 2022."
https://t.co/2Ix6xR9NEd
Congratulations to @UltimaGenomics and its UG100 sequencer for making @TheScientistLLC's Top 10 Innovations of 2022 list.
Ultima’s sequencing technology ensures that genetic sequencing is no longer cost prohibitive for better patient care.
https://t.co/G4H5iDYfom
If you suffer from migraine you should try Nerivio, the non-drug solution by Theranica. The company just raised a significant round to continue its growth worldwide.
https://t.co/EgqMirsYzs
API availability continues to grow rapidly in commercial insurance, but knowing where to go has remained tricky. Check out this exciting resource from the team at @HeraldAPI, who remain at the leading edge of the connectivity problem in insurance:
https://t.co/XUqnLNaHSI
.@AirDoctorApp addresses a major pain point for the health and travel insurance industry, and @lightspeedvp is excited to lead the company's new $20m financing round. More details below.
Why @lightspeedvp's investment in @UltimaGenomics is a win for patient care. The $100 genome will revolutionize the care ecosystem.
https://t.co/gIuK06fCl2
.@HeraldAPI addresses a major pain point for the nearly US$300 billion commercial insurance industry, and @lightspeedvp is excited to lead the company’s new $8 million funding round. Read more about the team and our investment thesis on the blog: https://t.co/wCmScBC1A3
.@KeepRisk_AtBay continues to prove itself as an innovator in cyber insurance. We @lightspeedvp believe in At-Bay’s vision of challenging industry conventions and reimagining ways to assess cyber risk, which is why we have supported the company every step of the way.
We’re happy to share that At-Bay closed a $185M Series D round — led by @iconventures and @lightspeedvp — that puts our valuation at $1.35B.
https://t.co/jJczzsItuE
1/4 I am proud to congratulate @yarongalai@orilahav David Kostman and the @Outbrain team on their initial public offering on the @Nasdaq today. https://t.co/Vl6zV6PMeM
3/4 Lightspeed has been investing in early-through-growth-stage Israeli-based companies for more than a decade, and @Outbrain is one of several major public offerings to come out of Israel over the past month.
https://t.co/heS27UEuZH
Migraine effects millions. New, non-drug, treatments (https://t.co/oPHibEKxfJ) approved by the FDA with clinical efficacy better than drugs. Insurance companies need to make these treatments affordable.
Note: I'm a director at https://t.co/52z3gRC8yV